Jason Laine

CBD’s Promise And Limits For Pain Relief 0
- CANNABIS OIL
- February 17, 2026
Cannabidiol is emerging as a popular option for people seeking pain relief without the intoxicating effects associated with THC. Drawing on survey data and clinical reviews, Forbes Health reports that many adults now use CBD for conditions such as arthritis, chronic pain and joint discomfort, often noting improvements in sleep and physical function. At the
READ MORE
Rescheduling Marijuana: Three Paths, High Stakes 0
- MEDICAL MARIJUANA
- February 12, 2026
Medical marijuana in the U.S. is at a crossroads as federal officials move to shift it from the tightly restricted Schedule I category toward Schedule III, following an executive order signed by President Donald Trump in December 2025 and a process begun under President Joe Biden in 2022. This change could ease research barriers and
READ MORE

Somerset Family Urges NHS to Fund Life-Changing Medical Cannabis 0
- CANNABIS OIL
- February 11, 2026
Emily and Spencer, parents from Nunney near Frome, say medical cannabis has transformed the life of their six-year-old daughter, Clover, who suffers from Aicardi Syndrome. Since starting treatment in 2020, her seizures have drastically reduced—from dozens daily to just a few mild ones—though the family spends £750 a month on privately sourced cannabis oil. After
READ MORE
Marijuana Legalization Edges Closer to U.S. Mainstream 0
- MEDICAL MARIJUANA
- February 6, 2026
Once criminalized nationwide by the Marihuana Tax Act of 1937, cannabis is now legal in some form across most U.S. states, with many authorizing medical use and a growing cohort permitting recreational sales. Yet federal law still classifies marijuana as a Schedule I drug under the Controlled Substances Act, creating a clash between Washington and
READ MORE